Furthermore, by integrating clinical data from a large patient cohort, in vitro functional assays, and in vivo xenograft models, our work provides a comprehensive demonstration of furin’s dual role in CRC progression and therapeutic resistance. Here, FURIN is linked to colorectal carcinoma.